R94.39: Abnormal result of other cardiovascular function study

R94.39, abnormal result of other cardiovascular function study, is listed as a covered diagnosis in 6 Medicare billing and coding articles that apply to 21 HCPCS Level II codes, including A9700 (Supply of injectable contrast material for use in…), J0153 (Injection, adenosine, 1 mg (not to be used to report any…), J1250 (Injection, dobutamine hydrochloride, per 250 mg). The articles come from 4 Medicare contractors. A listed diagnosis supports medical necessity only; coverage still depends on the LCD's criteria and on documentation in the medical record.

HCPCS Level II codes with R94.39 as a covered diagnosis

CodeDescriptionMedicare coverageDMEPOS fee 2026 (state range)Articles listing it
A9700Supply of injectable contrast material for use in echocardiography, per studySpecial coverage instructions apply—2
J0153Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)Special coverage instructions apply—3
J1250Injection, dobutamine hydrochloride, per 250 mgSpecial coverage instructions apply—3
J1245Injection, dipyridamole, per 10 mgSpecial coverage instructions apply—3
Q9957Injection, perflutren lipid microspheres, per mlCarrier judgment—1
Q9956Injection, octafluoropropane microspheres, per mlCarrier judgment—1
Q9950Injection, sulfur hexafluoride lipid microspheres, per mlCarrier judgment—1
Q9955Injection, perflexane lipid microspheres, per mlCarrier judgment—1
G0278Iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation (list separately in addition to primary procedure)Carrier judgment—2
G0269Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g., angioseal plug, vascular plug)Special coverage instructions apply—2
J0461Injection, atropine sulfate, 0.01 mgSpecial coverage instructions apply—2
J0280Injection, aminophyllin, up to 250 mgSpecial coverage instructions apply—2
J3490Unclassified drugsSpecial coverage instructions apply—1
A9500Technetium tc-99m sestamibi, diagnostic, per study doseCarrier judgment—1
A9502Technetium tc-99m tetrofosmin, diagnostic, per study doseCarrier judgment—1
A9555Rubidium rb-82, diagnostic, per study dose, up to 60 millicuriesCarrier judgment—1
A9505Thallium tl-201 thallous chloride, diagnostic, per millicurieCarrier judgment—1
A9526Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuriesCarrier judgment—1
A4641Radiopharmaceutical, diagnostic, not otherwise classifiedCarrier judgment—1
A9501Technetium tc-99m teboroxime, diagnostic, per study doseCarrier judgment—1
A9611Flurpiridaz f 18, diagnostic, 1 millicurieCarrier judgment—1

Medicare policy articles listing R94.39

A diagnosis listed as covered in a billing and coding article supports medical necessity for the article's codes; it does not guarantee payment. Coverage depends on the LCD's criteria, the contractor's jurisdiction and documentation in the medical record.

Other R94 diagnoses (Abnormal results of function studies)

Frequently asked questions

Does Medicare cover R94.39 (Abnormal result of other cardiovascular function study)?

Medicare covers items and services, not diagnoses. 6 Medicare billing and coding articles list R94.39 as a covered diagnosis for 21 HCPCS Level II codes: the diagnosis can support medical necessity for those codes, but payment still depends on the LCD's coverage criteria and the medical record.

Which HCPCS codes can be billed with ICD-10 R94.39?

The Level II codes from the policies most specific to this diagnosis are A9700 (Supply of injectable contrast material for use in…, 2 articles); J0153 (Injection, adenosine, 1 mg (not to be used to report any…, 3 articles); J1250 (Injection, dobutamine hydrochloride, per 250 mg, 3 articles); J1245 (Injection, dipyridamole, per 10 mg, 3 articles); Q9957 (Injection, perflutren lipid microspheres, per ml, 1 article). Code choice depends on the item supplied; check each code's descriptor.

Which Medicare policy articles list R94.39?

A58503 (Billing and Coding: Echocardiography for Myocardial Perfusion); A57183 (Billing and Coding: Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography); A56500 (Billing and Coding: Cardiac Catheterization and Coronary Angiography), and 3 more articles.

What is ICD-10-CM code R94.39?

R94.39 is the ICD-10-CM code for abnormal result of other cardiovascular function study, in category R94 (Abnormal results of function studies), chapter 18: Symptoms, signs and abnormal findings.

Next steps

Sources: CMS Medicare Coverage Database billing and coding articles (covered ICD-10 code lists and HCPCS links); ICD-10-CM FY2026; CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule 2026 (non-rural state fees). Not billing or legal advice.

Chapter 18: Symptoms, signs and abnormal findings · All diagnoses · HCPCS lookup